Google Alert - lung cancer survival

News 5 new results for lung cancer survival

Analyst sees promise in Pfizer lung cancer drug Forbes AP , 06.16.11, 11:48 AM EDT INDIANAPOLIS -- A potential treatment for advanced lung cancer from Pfizer Inc. has about an 80 percent chance of receiving Food and Drug Administration approval this year, according to a Credit Suisse analyst. ... See all stories on this topic »

Cancer more likely to kill people in deprived areas, study shows The Guardian ... shows the gap in survival between the rich and poor in England remains substantial. If health outcomes were equal, 490 deaths from breast cancer could be averted, 330 from lung cancer, 690 from bowel cancer and 330 from prostate cancer. ... See all stories on this topic » The Guardian

When Two Cancer Drugs Are Better Than One BusinessWeek Merck (MRK) and AstraZeneca (AZN) in 2009 became the first rivals to join forces to test two experimental cancer drugs as a single therapy. They're initially targeting lung cancer. Their trial combines Merck's drug, which works against a protein called ... See all stories on this topic »

Transplant in First Remission Holds Off Progression in Non-Hodgkin's Lymphoma Internal Medicine News Digital Network The estimated 2-year progression-free survival rate reached 69% among patients who were randomized to receive the CHOP regimen with or without rituximab for six cycles, followed by an autologous stem cell transplant (ASCT). In comparison, only 56% of ... See all stories on this topic »

Life expectancy declining in many parts of US World Socialist Web Site Despite the overall decline in smoking from 1965 on, after the Surgeon General's report identified smoking as a major cause of cancer and lung disease, American women have ever since had a higher rate of smoking than women in other countries, ... See all stories on this topic »

---

Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn more.

Remove this alert.
Create another alert.
Manage your alerts.